You can buy or sell Neuronetics and other stocks, options, ETFs, and crypto commission-free!
Neuronetics, Inc. commercial stage medical technology company. It focuses on designing, developing and marketing products for the patients suffering from psychiatric disorders. Read More The firm offers NeuroStar TMS, a therapy system for the treatment of major depressive disorders in adult patients. It also provides a range of support services, including patient education, practice data management system, and customer and technical services to help the client start and manage TMS therapy systems. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon and Thomas D. Weldon in April 2003 and is headquartered in Malvern, PA.
52 Week High
52 Week Low
Advertising and Marketing
PR NewswireMar 21
Neuronetics, Inc. Celebrates Dr. Charles Epstein's Contributions to Magnetic Stimulation Research
MALVERN, Pa., March 21, 2019 /PRNewswire/ -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, applauds Dr. Charles M. Epstein, the neurologist who introduced magnetic stimulation at Emory University, for receiving the Start-Up of the Year Award at the 13th Annual Celebration of Technology and Innovation. The annual program is hosted by Em...
Simply Wall StMar 8
Is Neuronetics, Inc. (NASDAQ:STIM) A Financially Sound Company?
Neuronetics, Inc. (NASDAQ:STIM) is a small-cap stock with a market capitalization of US$282m. While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, they end up ignoring a key aspect, which could be the biggest threat to its existence: its financial health. Why is it important? Since STIM is loss-making right now, it’s vital to understand the current state of its operations and pathway to profitability. The following basic checks can help you get a pict...
Seeking AlphaMar 5
Neuronetics, Inc. (STIM) CEO Chris Thatcher on Q4 2018 Results - Earnings Call Transcript
Neuronetics, Inc. (NASDAQ:STIM) Q4 2018 Results Conference Call March 5, 2019 8:30 AM ET Company Participants Mark Klausner - IR, Westwicke Chris Thatcher - CEO Peter Donato - CFO Conference Call Participants Margaret Kaczor - William Blair Dave Turkaly - JMP Securities Matthew O'Brien - Piper Jaffray Cecilia Furlong - Canaccord Genuity Alex Silverman - Special Situations Operator Good day, ladies and gentlemen, and welcome to the Neuronetics Fourth Quarter and Full Year 2018 Earnings Conference...
Expected May 2, Pre-Market